These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 4623743

  • 1. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW, Jessamine AG, Eidus L.
    Can Med Assoc J; 1972 Apr 22; 106(8):884-8. PubMed ID: 4623743
    [Abstract] [Full Text] [Related]

  • 2. Rifampin.
    Schonell M, Dorken E, Grzybowski S.
    Can Med Assoc J; 1972 Apr 08; 106(7):783-6. PubMed ID: 4622757
    [Abstract] [Full Text] [Related]

  • 3. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW, Snider DE, Farer LS.
    Am Rev Respir Dis; 1979 Jun 08; 119(6):879-94. PubMed ID: 110184
    [Abstract] [Full Text] [Related]

  • 4. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J.
    Pneumonol Pol; 1976 Jun 08; 44(1):55-60. PubMed ID: 821043
    [No Abstract] [Full Text] [Related]

  • 5. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 08; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 6. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R, Doster B, Murray FJ, Ferebee S.
    Am Rev Respir Dis; 1971 Apr 08; 103(4):461-76. PubMed ID: 4994459
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 08; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 8. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M, Bek E, Kucharska A, Graczyk J, Bukalska Z.
    Gruzlica; 1973 Nov 08; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG, Johansson R, Tegner KB.
    Scand J Respir Dis; 1973 Nov 08; 54(5):255-63. PubMed ID: 4777378
    [No Abstract] [Full Text] [Related]

  • 12. Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
    Corpe R.
    Bull Int Union Tuberc; 1972 Feb 08; 47():41-7. PubMed ID: 4562017
    [No Abstract] [Full Text] [Related]

  • 13. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV, Ushkin VV.
    Antibiotiki; 1971 May 08; 16(5):472-7. PubMed ID: 5002224
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L, Mbete S, Van Landuyt H, Darras T, Gyselen A.
    Chest; 1972 Jun 08; 61(6):555-63. PubMed ID: 4624278
    [No Abstract] [Full Text] [Related]

  • 15. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V, Catena E, Delli Veneri F, De Michele G, Marra A.
    Am Rev Respir Dis; 1971 Mar 08; 103(3):329-37. PubMed ID: 5005040
    [No Abstract] [Full Text] [Related]

  • 16. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J.
    Pneumonol Pol; 1976 Feb 08; 44(2):153-61. PubMed ID: 940788
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W, Stanczuk A, Znaniecka H, Cesarz-Fronczyk M.
    Z Erkr Atmungsorgane; 1976 May 08; 145(2):220-6. PubMed ID: 983179
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 May 08; 26(4):193-205. PubMed ID: 204971
    [Abstract] [Full Text] [Related]

  • 20. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D, Anschel R, Eule H, Fichtner K, Ganguin HG, Pickroth G.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 May 08; 138(1):135-8. PubMed ID: 4491710
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.